1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Small Business Technology Transfer (STTR) Grants - Phase I (R41)" is currently closed and not accepting applications.
Small Business Technology Transfer (STTR) Grants - Phase I (R41) is sponsored by National Institutes of Health (NIH). This program helps small businesses that partner with a nonprofit research institution bring scientific innovations to the marketplace. Phase I awards focus on the feasibility, technical merit, and commercial potential of the research project.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Small Business Technology Transfer (STTR) Grants - Phase I (R41) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Small Business Technology Transfer (STTR) Grants - Phase I (R41) To help small businesses that partner with a nonprofit research institution bring scientific innovations to the marketplace.
The STTR supports research and development (R&D) awards to eligible United States small business concerns only. Note: General Small Business Information Visit Small Business for general guidance, policy, and program information. Find ICO Specific Information Funding Considerations and The focus of a Phase 1 award is on the feasibility, technical merit, and commercial potential of the research project.
Carefully read the Eligibility section of the funding opportunity for opportunity-specific organization eligibility requirements. Project Director/ Principal Investigator (PD/PI) Eligibility PD/PI must be employed by either the partnering research institution or small business. Carefully read the Eligibility section of the funding opportunity for opportunity-specific PD/PI eligibility requirements.
Standard Due Dates apply. Standard Application Due Dates (when applicable) NIH SEED: Understanding SBIR and STTR website NIH Grants Policy Statement Section 18. 5 Small Business Innovation Research and Small Business Technology Transfer Programs For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: United States small business concerns. Collaborating research institutions (e.g., universities) are subcontractors to the small businesses and may not apply as applicants. The Project Director/Principal Investigator (PD/PI) must be employed by either the partnering research institution or the small business. Confirm the full requirements in the official notice before applying.
The most recent published deadline was April 5, 2005, which has passed. This is an annual program, so a new cycle should follow. Check the funder's website for the next application window.
Small Business Technology Transfer (STTR) Grants - Phase I (R41) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article